![]() Severe allergic reactions have been reported following administration of aztreonam for injection to patients with no known history of exposure to aztreonam. To reduce the development of drug-resistant bacteria and maintain the effectiveness of CAYSTON and other antibacterial drugs, CAYSTON should be used only to treat patients with CF known to have ![]() Safety and effectiveness have not been established in pediatric patients below the age of 7 years, patients with FEV 1 75% predicted, or patients colonized with Burkholderia cepacia. Medicare Part D enrollees, while in the prescription drug coverage gap (the "donut hole"), are not eligible for the co-pay couponĬAYSTON is indicated to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (Pa). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |